跳至主要内容
临床试验/IRCT20210524051376N1
IRCT20210524051376N1招募中3 期

The effect of herbal product from Berberis integerrima on ultrasound image echogenicity of patients with Non-Alcoholic Fatty Liver Disease

Babol University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • Increased liver echogenicity (grade 2 non-alcoholic fatty liver) based on ultrasonographic findings

排除标准

  • The underlying illness (Diabetes mellitus, cardiovascular diseases, liver disease (cirrhosis, alcoholic liver disease, viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, biliary obstruction, hepatic damage induced by hereditary hemochromatosis drugs, sclerosis cholangitis and a deficiency of an antitrypsin), other serious diseases such as cancer; kidney failure and celiac disease
  • Drug history with increase hepatic steatosis risk (Tamoxifen, valproate sodium, ...
  • Antihyperlipidemic drugs
  • Malnutrition
  • special diets such as vegetarianism and raw eating
  • Alcohol consumption
  • Smoking and addiction
  • Acute psychiatric disorder

研究者

相似试验